Solventum Co. (NYSE:SOLV) Shares Sold by Lee Danner & Bass Inc.

Lee Danner & Bass Inc. lessened its holdings in Solventum Co. (NYSE:SOLV) by 5.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,029 shares of the company’s stock after selling 248 shares during the period. Lee Danner & Bass Inc.’s holdings in Solventum were worth $266,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. Modus Advisors LLC acquired a new position in Solventum during the 4th quarter worth about $25,000. Stonebridge Financial Group LLC acquired a new position in Solventum during the 4th quarter worth about $26,000. True Wealth Design LLC lifted its stake in Solventum by 23,550.0% during the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after acquiring an additional 471 shares in the last quarter. Crews Bank & Trust acquired a new position in Solventum during the 4th quarter worth about $32,000. Finally, Prospera Private Wealth LLC acquired a new position in Solventum during the 3rd quarter worth about $35,000.

Wall Street Analyst Weigh In

Several research firms recently issued reports on SOLV. The Goldman Sachs Group increased their target price on Solventum from $63.00 to $71.00 and gave the stock a “sell” rating in a research note on Monday, March 3rd. Morgan Stanley increased their target price on Solventum from $73.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Wednesday, March 5th. Mizuho increased their target price on Solventum from $70.00 to $82.00 and gave the stock a “neutral” rating in a research note on Monday, March 3rd. Bank of America increased their price target on Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a research report on Wednesday, February 26th. Finally, Wells Fargo & Company increased their price target on Solventum from $73.00 to $75.00 and gave the company an “equal weight” rating in a research report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, Solventum has a consensus rating of “Hold” and an average price target of $79.86.

Solventum Trading Down 1.3 %

SOLV opened at $74.00 on Friday. Solventum Co. has a one year low of $47.16 and a one year high of $85.92. The company has a market cap of $12.80 billion and a P/E ratio of 26.91. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. The business’s 50-day simple moving average is $75.17 and its 200-day simple moving average is $71.51.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.